Bronchial asthma has had some new drugs promoted in the clinic in recent years.
1. Fluticasone vilanterol furoate, which is also a combination of a long-acting β2 agonist and an inhaled glucocorticoid, has a longer duration of efficacy than traditional drugs and only needs to be administered once a day.
2. Targeted drugs: currently used in the clinic have anti-IgE monoclonal antibodies such as omalizumab; anti-interleukin antibodies such as mepolizumab, etc., these targeted drugs for the treatment of bronchial asthma is more expensive, often used in some patients with refractory asthma.
If the patient has bronchial asthma, please go to the regular hospital, the specific use of drugs need to be combined with my condition under the guidance of a professional doctor.